Abstract
Background and ImportanceInvestigational drug products (IDP) should be treated as hazardous drugs (HD) as it is not frequent to have hazard studies available or the information about safety is usually...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: European Journal of Hospital Pharmacy: Science and Practice
Paper Title
Journal
Date
